Associated Papers
Cardiovascular Pharmacogenomics: An Update on Clinical Studies of Antithrombotic Drugs in Brazilian Patients.
Hirata TDC et al.
Molecular Diagnosis & Therapy, 2021
Translational Pharmacogenomics: Discovery, Evidence Synthesis and Delivery of Race-Conscious Medicine.
Davis BH et al.
Clinical Pharmacology and Therapeutics, 2021
Genotype and Phenotype Concordance for Pharmacogenetic Tests Through Proficiency Survey Testing.
Moyer AM et al.
Archives of Pathology & Laboratory Medicine, 2020
The pharmacogenetics of the response to warfarin in Chinese.
Lam MP et al.
British Journal of Clinical Pharmacology, 2012
Development of cocaine-induced interstitial lung damage in two CYP2C and VKORC1 variant allele carriers.
Wijnen PA et al.
Molecular Diagnosis & Therapy, 2011
Implementing genotype-guided antithrombotic therapy.
Seip RL et al.
Future Cardiology, 2010
Pharmacogenetics of warfarin: current status and future challenges.
Wadelius M et al.
The Pharmacogenomics Journal, 2007
VKORC1 gene variations are the major contributors of variation in warfarin dose in Japanese patients.
Obayashi K et al.
Clinical Pharmacology and Therapeutics, 2006
[Cardiovascular pharmacogenomics].
Scibona P et al.
Archivos De Cardiologia De Mexico, 0
Select a paper to view details